Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-up
- 5 February 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (3), 257-258
- https://doi.org/10.1093/jnci/89.3.257
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessmentNature Medicine, 1996
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- Detection of Chromosomal Polysomy in Oral Leukoplakia, a Premalignant LesionJNCI Journal of the National Cancer Institute, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Comparison of Low-Dose Isotretinoin with Beta Carotene to Prevent Oral CarcinogenesisNew England Journal of Medicine, 1993
- Validation of Intermediate End Points in Cancer ResearchJNCI Journal of the National Cancer Institute, 1990
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- Biomarkers as Intermediate End Points in Chemoprevention TrialsJNCI Journal of the National Cancer Institute, 1990
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- Oral leukoplakia and malignant transformation. A follow-up study of 257 patientsCancer, 1984